"HIV-1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte.
| Descriptor ID |
D015497
|
| MeSH Number(s) |
B04.820.650.589.650.350.400
|
| Concept/Terms |
HIV-1- HIV-1
- Human immunodeficiency virus 1
- HIV-I
- Immunodeficiency Virus Type 1, Human
- Human Immunodeficiency Virus Type 1
|
Below are MeSH descriptors whose meaning is more general than "HIV-1".
Below are MeSH descriptors whose meaning is more specific than "HIV-1".
This graph shows the total number of publications written about "HIV-1" by people in this website by year, and whether "HIV-1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 11 | 3 | 14 |
| 1996 | 6 | 2 | 8 |
| 1997 | 5 | 0 | 5 |
| 1998 | 10 | 1 | 11 |
| 1999 | 5 | 3 | 8 |
| 2000 | 6 | 1 | 7 |
| 2001 | 9 | 3 | 12 |
| 2002 | 16 | 2 | 18 |
| 2003 | 3 | 3 | 6 |
| 2004 | 9 | 4 | 13 |
| 2005 | 3 | 4 | 7 |
| 2006 | 14 | 4 | 18 |
| 2007 | 9 | 2 | 11 |
| 2008 | 11 | 2 | 13 |
| 2009 | 7 | 5 | 12 |
| 2010 | 12 | 4 | 16 |
| 2011 | 8 | 4 | 12 |
| 2012 | 13 | 4 | 17 |
| 2013 | 12 | 3 | 15 |
| 2014 | 9 | 5 | 14 |
| 2015 | 8 | 5 | 13 |
| 2016 | 9 | 8 | 17 |
| 2017 | 10 | 1 | 11 |
| 2018 | 10 | 8 | 18 |
| 2019 | 4 | 3 | 7 |
| 2020 | 7 | 5 | 12 |
| 2021 | 3 | 1 | 4 |
| 2022 | 6 | 0 | 6 |
| 2023 | 11 | 0 | 11 |
| 2024 | 7 | 2 | 9 |
| 2025 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "HIV-1" by people in Profiles.
-
Determinants of successful AAV-vectored delivery of HIV-1 bNAbs in early life. Nature. 2025 Sep; 645(8082):1020-1028.
-
Apollo: a comprehensive GPU-powered within-host simulator for viral evolution and infection dynamics across population, tissue, and cell. Nat Commun. 2025 Jul 01; 16(1):5783.
-
In?vivo evolution of env in SHIV-AD8EO-infected rhesus macaques after AAV-vectored delivery of eCD4-Ig. Mol Ther. 2025 Feb 05; 33(2):560-579.
-
Emerging integrase resistance in an international perinatal virtual clinic. AIDS. 2025 Mar 01; 39(3):276-280.
-
Optimization of Cellular Transduction by the HIV-Based Pseudovirus Platform with Pan-Coronavirus Spike Proteins. Viruses. 2024 09 20; 16(9).
-
Identification of a Clade-Specific HLA-C*03:02 CTL Epitope GY9 Derived from the HIV-1 p17 Matrix Protein. Int J Mol Sci. 2024 Sep 06; 25(17).
-
Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fc? receptors during acute SHIVAD8-EO infection. Nat Commun. 2024 Aug 29; 15(1):7461.
-
Gene expression and chromatin conformation of microglia in virally suppressed people with HIV. Life Sci Alliance. 2024 Oct; 7(10).
-
Molecular Transmission Network and Drug Resistance in Treatment-Naive HIV-1-Infected Patients in the Liangshan District, China. AIDS Res Hum Retroviruses. 2024 Aug; 40(8):489-495.
-
False-Reactive Fourth-Generation Human Immunodeficiency Virus Testing in Cancer Patients. Clin Infect Dis. 2024 03 20; 78(3):674-680.